For Me, Quality of Life Is When I Get Through the Day Without Thinking: I Won't Make It: A Participatory Qualitative Study of Health‐Related Quality of Life in Rare Liver Diseases
Health Expectations · 2026-06 · 29 (3)
DOI: 10.1111/hex.70721 ↗At a glance
Qualitative Studie in Health Expectations, published online on 2026-06-14. Written by Anouck Alary and 17 co-authors. Institution: INSERM, Aix-Marseille Univ, IRD, ISSPAM, SESSTIM (Economic and Social Sciences of Health and Medical Information Processing), CALIPSO team, Marseille…. Major MEDLINE topics: Quality of Life, Liver Diseases, Rare Diseases. Cited 1 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Union's Horizon 2020 Research and Innovation Programme, ANR, FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen).
Abstract (original language)
Background
Vascular liver diseases (VLDs) predominantly affect young adults and require lifelong monitoring. The health‐related quality of life (HRQoL) of patients with VLDs is deteriorated, with high levels of fatigue and depressive symptoms, but their lived experience and unmet needs remain unknown. To fully integrate the patients’ perspective and generate actionable insights, we conducted a qualitative peer‐research study.
Methods
Twelve peer researchers conducted interviews with patients in France, Spain, Switzerland, and the Netherlands. Analysis proceeded in three phases: individual inductive thematic analysis independently made by peer and academic researchers, followed by an international workshop to build a shared thematic framework. Third, directed content analysis, informed by the shared framework, was made by an academic researcher.
Results
From 27 interviews, five themes were identified, mapping the disease's impact on quality of life from diagnosis onward, and throughout the patient journey. First, the diagnosis trajectory was characterised by ‘uncertainty and biographical disruption’. Then, long‐term symptoms were described as impacting daily life through the experience of ‘chronic uncertainty, loss of ability and social exclusion’. Participants’ accounts also reflected the social impact of VLDs, which resulted in ‘renegotiating roles, ties and identities’. All along the care journey, their healthcare experience could be marked by ‘relational and institutional gaps shaping illness experience’. Finally, ‘the sense of belonging to a community of peers’ was highlighted as a potential but lacking resource.
Conclusions
Living with a rare VLD involves uncertainty, unpredictable fatigue, stigma, and social disruption, alongside efforts to maintain dignity and autonomy. While patients can demonstrate resilience, this does not negate ongoing needs. Improving quality of life requires addressing not only symptoms such as fatigue, anxiety or sexual dysfunction but requires guidance on physical activity, nutrition or occupational and financial challenges. Patient and Public Contribution Ten patients and two caregivers were involved as peer researchers throughout the study, ensuring that priorities, interpretations, and conclusions reflected patient‐defined concerns. All peer researchers contributed to the design, data collection and analysis activities. Due to professional and health constraints, about half of the PRs could only participate in the first local analysis phase. PRs were financially compensated.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- INSERM, Aix-Marseille Univ, IRD, ISSPAM, SESSTIM (Economic and Social Sciences of Health and Medical Information Processing), CALIPSO team, Marseille, France.
- Rotterdam University of Applied Sciences, Research Centre Innovations in Care, Rotterdam, The Netherlands.
- UCLouvain, Institute of Health & Society, Academic Centre for health promotion-RESO, Brussels, Belgium.
- Miguel Hernandez University of Elche, Department of Health Psychology, Elche, Spain.
- FISABIO, Alicante-Sant Joan Healthcare District, Alicante, Spain.
- SUPSI (University of Applied Sciences and Arts in Southern Switzerland), DEASS (Department of Business Economics, Health and Social Care), CPPS (Competence Centre for Healthcare Practices and Policies), Manno, Switzerla…
ORCID profiles: Anouck Alary
Funding
- European Union's Horizon 2020 Research and Innovation Programme
- ANR
- FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen)
- SNF (Swiss National Science Foundation)
- Instituto de Salud Carlos III (reference AC21_2/00029)
- Agence Nationale de la Recherche
Cite
APA
Alary, A., Sattoe, J., Sifer-Rivière, L., Aujoulat, I., Mira, J., Bernegger, G., Danesi, G., Gil-Hernández, E., Ballester, P., Guilabert, M., Nipius, D., Kousemaker-Nieuwdorp, J., van der Meer-Kuiper, K., Cannavò, S., Drossart, C., Veniat, L., Zufferey, M. C., & Dumas, A. (2026). For Me, Quality of Life Is When I Get Through the Day Without Thinking: I Won't Make It: A Participatory Qualitative Study of Health‐Related Quality of Life in Rare Liver Diseases. Health Expectations, 29(3). https://doi.org/10.1111/hex.70721
Vancouver
Alary A, Sattoe J, Sifer-Rivière L, Aujoulat I, Mira J, Bernegger G, et al. For Me, Quality of Life Is When I Get Through the Day Without Thinking: I Won't Make It: A Participatory Qualitative Study of Health‐Related Quality of Life in Rare Liver Diseases. Health Expectations. 2026;29(3). doi:10.1111/hex.70721
BibTeX
@article{Alary2026,
author = {Alary, Anouck and Sattoe, Jane and Sifer-Rivière, Lynda and Aujoulat, Isabelle and Mira, José and Bernegger, Guenda and Danesi, Giada and Gil-Hernández, Eva and Ballester, Pura and Guilabert, Mercedes and Nipius, Doortje and Kousemaker-Nieuwdorp, Jeanina and van der Meer-Kuiper, Kay and Cannavò, Stefania and Drossart, Cecile and Veniat, Liliane and Zufferey, María Caiata and Dumas, Agnes},
title = {For Me, Quality of Life Is When I Get Through the Day Without Thinking: I Won't Make It: A Participatory Qualitative Study of Health‐Related Quality of Life in Rare Liver Diseases},
journal = {Health Expectations},
year = {2026},
volume = {29},
number = {3},
doi = {10.1111/hex.70721}
}
EUVIMED